The articles, information, and content displayed on this webpage may include materials prepared and provided by third parties
The most commonly reported adverse drug reactions (ADRs) associated with GLP-1 therapies are gastrointestinal, including nausea, diarrhea, constipation, and vomiting
Hydrogen sulfide from adipose tissue is a novel insulin resistance regulator
The FDA recommends clinicians be well-informed when prescribing medications off-label
Women experience more slowing effects, especially when taking longer-lasting versions [7]
A small subset of people may not lose significant weight at all on GLP-1s, which is a different issue from plateauing after initial loss